TMEFF2


Summary: This gene encodes a member of the tomoregulin family of transmembrane proteins. This protein has been shown to function as both an oncogene and a tumor suppressor depending on the cellular context and may regulate prostate cancer cell invasion. Multiple soluble forms of this protein have been identified that arise from both an alternative splice variant and ectodomain shedding. Additionally, this gene has been found to be hypermethylated in multiple cancer types. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015].

NameOMIM IDEnsembl IDHGNC IDPHARMGKB IDMap Location
transmembrane protein with EGF like and two follistatin like domains 2MIM:605734Ensembl:ENSG00000144339HGNC:HGNC:11867PA365682q32.3

Gene Categories:

DRUGGABLE GENOME

GO terms in TMEFF2


Term TypeEvidence TypeGO Term IDGO Des.
BPIDAGO:0030336negative regulation of cell migration
BPIDAGO:0044319wound healing, spreading of cells
BPIMPGO:0045720negative regulation of integrin biosynthetic process
BPIDAGO:0051497negative regulation of stress fiber assembly
CCIEAGO:0005576extracellular region
CCNASGO:0016021integral component of membrane
MFNDGO:0003674molecular_function

Gene expression in normal tissue: TMEFF2

Gene-model tissue-cancer distribution: Bubble Plot

Gene-drug pathway distribution

Pathways in TMEFF2


DatabasePathway IDPathway Des.
pidmyc_represspathwayValidated targets of C-MYC transcriptional repression

Gene-Drug: Aster Plot


Drug IDDrug NameModel Num.
iGMDRD133Lapatinib1

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in TMEFF2

​​​​